Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysisİrem Öner, Pınar KaraçinInternational Journal of Clinical Oncology|April 21, 2025
PIV and PILE scores predict the clinical outcome in patients with metastatic breast cancer treated with CDK4/6 inhibitorsTuğba Önder, İrem Öner, Cengiz Karaçin, et al.Clinical Breast Cancer|June 15, 2024
Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 InhibitorsTuğba Önder, Öztürk Ateş, İrem Öner, et al.Japanese Journal of Clinical Oncology|February 25, 2025
Valuable predictive power of prognostic nutritional index in metastatic breast cancer patients treated with CDK4/6 inhibitorsTuğba Önder, İrem Öner, Cengiz Karaçin, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 10, 2023
Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancerAlper Türkel, Cengiz Karaçin, İrem Öner, et al.Future Oncology (London, England)|November 26, 2024
Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancerİrem Öner, Alper Türkel, Hicran Anık, et al.BMC Cancer|October 31, 2024
Impact of the CPS-EG score as a new prognostic biomarker in triple-negative breast cancer patients who received neoadjuvant chemotherapyİrem Öner, Alper Türkel, Bediz Kurt İnci, et al.Current Oncology (Toronto, Ont.)|October 25, 2024
Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular VolumeBediz Kurt İnci, Pınar Kubilay Tolunay, Şura Öztekin, et al.Medicina (Kaunas, Lithuania)|February 26, 2025
A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapyİrem Öner, Hicran Anık, Bediz Kurt İnci, et al.Annals of Human Genetics|August 29, 2024
Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancerAlper Türkel, Ilknur Deliktaş Onur, Hicran Anik, et al.Pageof 2